Tren- great medication, which gives excellent results on the path of "solo" to increase muscle mass without the need to be combined with other medications. However, it is a very powerful steroid, and therefore do not exceed the recommended dosage of certain: for acetate - is 50mg per day for enthatate: 300-350mg per week. To test the tolerance of Tren is better to start with a minimum dosage. If the entire rate is not more than six weeks, the need for additional formulations appears; when 6 to 8 weeks, with the need to enter the second week Gonadotropin (500 / 1000ME every 7 days) and stop taking it two weeks after administration cycle. Next, we have to be post-cycle therapy: start 14 days after the last injection or after 3days (if used Tren Acetate). To restore testosterone production take testosterone boosters (4 weeks after the course).
Trenbolone acetate is a modified form of nandrolone.  The structure of trenbolone acetate is a 19-nor classification, which represents a structural change of the testosterone hormone. Trenbolone acetate lacks a carbon atom at the 19 position and carries a double bond at carbons 9 and 11. The position of these carbons slows its metabolism, which greatly increases its binding affinity to the AR, and inhibits it from undergoing aromatization into the corresponding estrogenic metabolite. Trenbolone acetate contains trenbolone modified with the addition of a carboxylic acid ester ( acetic acid ) at the 17β-hydroxyl group.  This facilitates the slow release of the AAS from the area of injection.
The next document issued was a proposed rule dated June 17, 1994, which states, “FDA is issuing a notice of proposed rulemaking in the form of an amended tentative final monograph that would establish conditions under which OTC topical health-care antiseptic drug products are generally recognized as safe and effective and not misbranded. FDA is issuing this notice of proposed rulemaking on topical antimicrobial drug products after considering the public comments on that notice and other information in the administrative record for this rulemaking. FDA is also requesting data and information concerning the safety and effectiveness of topical antimicrobials for use as hand sanitizers or dips.”  In the 1994 update to the rule, TCS was effectively removed from the drug category which made it available for use in consumer products.